We use cookies to keep our site safe and provide an enhanced, personalized experience. You can choose to accept or manage optional cookies. More details about how we protect and use your information can be found in our Privacy Policy.
Disease Modification
The Benefits of and Considerations for Using Disease-Modifying Therapies (DMTs) for Multiple Sclerosis
American Academy of Neurology Practice Guideline for the Use of DMTs
In September 2021, the American Academy of Neurology (AAN) reaffirmed its practice guideline for the use of disease-modifying therapies for adults with MS. These guidelines have been endorsed by the National Multiple Sclerosis Society and the Multiple Sclerosis Association of America. The guidelines address starting, switching and stopping DMTs for adults living with MS. The full guidelines and summaries are available for clinicians and patients." c-nmssatomrichtext_nmssatomrichtext-host="">
Under certain circumstances, some healthcare providers may use medications to treat MS that have FDA approval for other diseases, sometimes referred to as "off-label" use.
American Academy of Neurology Practice Guideline for the Use of DMTs
In September 2021, the American Academy of Neurology (AAN) reaffirmed its practice guideline for the use of disease-modifying therapies for adults with MS. These guidelines have been endorsed by the National Multiple Sclerosis Society and the Multiple Sclerosis Association of America. The guidelines address starting, switching and stopping DMTs for adults living with MS. The full guidelines and summaries are available for clinicians and patients.
Guidelines for Disease-Modifying Therapies for MS From the American Academy of Neurology